The phosphorylation of ERK1/2 downstream of PI3K mutations has been observed in breast cancer cells with PIK3CA mutations.32 Inhibition of PI3K in these cells was actually shown to inhibit phosphorylation of ERK1/2. Here, PIK3CA is linked to breast carcinoma.